 Narasimhan Rajaram
Concepts (201)
Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Spectrum Analysis | 13 | 2022 | 79 | 2.930 |
Why?
| | Oxygen | 7 | 2020 | 361 | 1.730 |
Why?
| | Optical Imaging | 7 | 2020 | 30 | 1.580 |
Why?
| | Radiation Tolerance | 3 | 2020 | 86 | 1.460 |
Why?
| | Tumor Microenvironment | 5 | 2022 | 209 | 1.220 |
Why?
| | Hemoglobins | 5 | 2022 | 126 | 1.200 |
Why?
| | Skin Neoplasms | 6 | 2022 | 532 | 1.070 |
Why?
| | Spectrometry, Fluorescence | 5 | 2015 | 53 | 1.000 |
Why?
| | Oxygen Consumption | 4 | 2020 | 223 | 0.950 |
Why?
| | Oxidation-Reduction | 3 | 2020 | 382 | 0.880 |
Why?
| | Radiation-Sensitizing Agents | 2 | 2018 | 55 | 0.790 |
Why?
| | Breast | 2 | 2021 | 92 | 0.790 |
Why?
| | Heat-Shock Response | 1 | 2021 | 29 | 0.780 |
Why?
| | Radiation | 1 | 2020 | 17 | 0.770 |
Why?
| | 4-Chloro-7-nitrobenzofurazan | 4 | 2015 | 6 | 0.770 |
Why?
| | Deoxyglucose | 4 | 2015 | 37 | 0.760 |
Why?
| | Cell Line, Tumor | 14 | 2024 | 1550 | 0.730 |
Why?
| | Hot Temperature | 1 | 2021 | 199 | 0.720 |
Why?
| | Head and Neck Neoplasms | 3 | 2019 | 335 | 0.710 |
Why?
| | Lung Neoplasms | 3 | 2024 | 642 | 0.650 |
Why?
| | Biosensing Techniques | 1 | 2018 | 28 | 0.650 |
Why?
| | Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2018 | 60 | 0.640 |
Why?
| | Indazoles | 1 | 2018 | 55 | 0.640 |
Why?
| | Carcinoma, Squamous Cell | 2 | 2019 | 384 | 0.630 |
Why?
| | Animals | 26 | 2024 | 14385 | 0.610 |
Why?
| | Mice | 19 | 2024 | 6413 | 0.600 |
Why?
| | Spectrum Analysis, Raman | 3 | 2022 | 68 | 0.580 |
Why?
| | Fluorescent Dyes | 2 | 2014 | 116 | 0.570 |
Why?
| | Epithelial Cells | 1 | 2018 | 255 | 0.570 |
Why?
| | Nephelometry and Turbidimetry | 3 | 2012 | 7 | 0.550 |
Why?
| | Photometry | 3 | 2012 | 17 | 0.540 |
Why?
| | Carcinoma | 2 | 2022 | 153 | 0.540 |
Why?
| | Enzyme Inhibitors | 1 | 2018 | 446 | 0.530 |
Why?
| | Foreign Medical Graduates | 1 | 2015 | 7 | 0.520 |
Why?
| | Health Care Sector | 1 | 2015 | 17 | 0.520 |
Why?
| | Policy | 1 | 2015 | 27 | 0.520 |
Why?
| | Models, Cardiovascular | 2 | 2013 | 29 | 0.500 |
Why?
| | Blood Vessels | 1 | 2015 | 78 | 0.500 |
Why?
| | Breast Neoplasms | 5 | 2018 | 1248 | 0.490 |
Why?
| | Algorithms | 4 | 2018 | 697 | 0.440 |
Why?
| | Glucose | 1 | 2015 | 366 | 0.430 |
Why?
| | Skin | 4 | 2018 | 469 | 0.420 |
Why?
| | Delivery of Health Care | 1 | 2015 | 327 | 0.410 |
Why?
| | Refractometry | 2 | 2012 | 7 | 0.400 |
Why?
| | Lasers, Gas | 1 | 2010 | 7 | 0.390 |
Why?
| | Lasers, Dye | 1 | 2010 | 10 | 0.390 |
Why?
| | Pigments, Biological | 1 | 2010 | 4 | 0.390 |
Why?
| | Mice, Nude | 5 | 2019 | 283 | 0.390 |
Why?
| | Microfluidics | 1 | 2010 | 7 | 0.380 |
Why?
| | Glycolysis | 3 | 2017 | 73 | 0.380 |
Why?
| | Carcinoma, Basal Cell | 1 | 2010 | 44 | 0.370 |
Why?
| | Colonic Neoplasms | 2 | 2022 | 164 | 0.370 |
Why?
| | Disease Models, Animal | 4 | 2020 | 1639 | 0.350 |
Why?
| | Models, Biological | 2 | 2012 | 823 | 0.330 |
Why?
| | Models, Chemical | 1 | 2008 | 65 | 0.330 |
Why?
| | Humans | 24 | 2024 | 54284 | 0.320 |
Why?
| | Image Interpretation, Computer-Assisted | 2 | 2018 | 119 | 0.300 |
Why?
| | Fiber Optic Technology | 2 | 2016 | 17 | 0.260 |
Why?
| | Microscopy, Fluorescence | 2 | 2018 | 198 | 0.250 |
Why?
| | Mammary Neoplasms, Experimental | 3 | 2018 | 135 | 0.250 |
Why?
| | Phantoms, Imaging | 5 | 2018 | 126 | 0.250 |
Why?
| | Neovascularization, Pathologic | 2 | 2018 | 168 | 0.250 |
Why?
| | Tumor Cells, Cultured | 3 | 2021 | 477 | 0.240 |
Why?
| | Fluorouracil | 2 | 2022 | 61 | 0.230 |
Why?
| | Xenograft Model Antitumor Assays | 2 | 2020 | 219 | 0.230 |
Why?
| | Scattering, Radiation | 4 | 2015 | 31 | 0.210 |
Why?
| | Neoplasms, Second Primary | 1 | 2022 | 77 | 0.210 |
Why?
| | Carcinoma, Non-Small-Cell Lung | 1 | 2024 | 164 | 0.210 |
Why?
| | CTLA-4 Antigen | 1 | 2021 | 29 | 0.210 |
Why?
| | Poultry | 1 | 2021 | 29 | 0.200 |
Why?
| | Female | 15 | 2021 | 28441 | 0.190 |
Why?
| | Meat | 1 | 2021 | 59 | 0.190 |
Why?
| | Animal Feed | 1 | 2021 | 64 | 0.190 |
Why?
| | Neoplasm Metastasis | 3 | 2022 | 252 | 0.190 |
Why?
| | Reproducibility of Results | 5 | 2012 | 1304 | 0.190 |
Why?
| | Sensitivity and Specificity | 4 | 2012 | 923 | 0.190 |
Why?
| | Chickens | 1 | 2021 | 118 | 0.190 |
Why?
| | Dose-Response Relationship, Radiation | 1 | 2020 | 204 | 0.190 |
Why?
| | Spectrophotometry | 1 | 2020 | 36 | 0.180 |
Why?
| | Antimetabolites, Antineoplastic | 1 | 2020 | 39 | 0.180 |
Why?
| | Equipment Design | 5 | 2014 | 318 | 0.180 |
Why?
| | Radiotherapy | 1 | 2020 | 138 | 0.180 |
Why?
| | Mice, Inbred BALB C | 4 | 2022 | 368 | 0.180 |
Why?
| | Mitochondria, Heart | 1 | 2019 | 42 | 0.170 |
Why?
| | Flavin-Adenine Dinucleotide | 1 | 2018 | 5 | 0.170 |
Why?
| | Granulocyte Colony-Stimulating Factor | 1 | 2018 | 69 | 0.170 |
Why?
| | Nitroimidazoles | 1 | 2018 | 17 | 0.160 |
Why?
| | NAD | 1 | 2018 | 46 | 0.160 |
Why?
| | Terahertz Imaging | 1 | 2018 | 1 | 0.160 |
Why?
| | Mammary Neoplasms, Animal | 1 | 2018 | 38 | 0.160 |
Why?
| | Neoplasms, Experimental | 1 | 2018 | 115 | 0.160 |
Why?
| | Organometallic Compounds | 1 | 2018 | 47 | 0.160 |
Why?
| | Cancer Vaccines | 1 | 2018 | 103 | 0.150 |
Why?
| | Immunohistochemistry | 1 | 2020 | 1089 | 0.150 |
Why?
| | Colorectal Neoplasms | 1 | 2020 | 236 | 0.150 |
Why?
| | Heart Valves | 1 | 2016 | 15 | 0.140 |
Why?
| | Cytoskeleton | 1 | 2016 | 50 | 0.140 |
Why?
| | Antineoplastic Agents | 2 | 2024 | 1300 | 0.140 |
Why?
| | Equipment Failure Analysis | 3 | 2012 | 49 | 0.140 |
Why?
| | Mouth | 1 | 2016 | 35 | 0.140 |
Why?
| | Myocardium | 1 | 2019 | 441 | 0.140 |
Why?
| | Muscle Contraction | 1 | 2016 | 109 | 0.140 |
Why?
| | Cell Nucleus | 1 | 2016 | 203 | 0.140 |
Why?
| | Melanoma | 2 | 2022 | 313 | 0.130 |
Why?
| | RNA, Messenger | 1 | 2019 | 1202 | 0.130 |
Why?
| | Models, Statistical | 2 | 2018 | 259 | 0.130 |
Why?
| | India | 1 | 2015 | 79 | 0.130 |
Why?
| | Blood Glucose | 2 | 2015 | 489 | 0.130 |
Why?
| | China | 1 | 2015 | 104 | 0.130 |
Why?
| | Transducers | 2 | 2012 | 20 | 0.130 |
Why?
| | Neoplasm Recurrence, Local | 1 | 2018 | 644 | 0.120 |
Why?
| | Energy Metabolism | 1 | 2016 | 311 | 0.120 |
Why?
| | Sulfur Dioxide | 1 | 2013 | 3 | 0.120 |
Why?
| | Blood Volume | 2 | 2011 | 69 | 0.120 |
Why?
| | Regional Blood Flow | 1 | 2013 | 121 | 0.120 |
Why?
| | HSP90 Heat-Shock Proteins | 1 | 2013 | 53 | 0.110 |
Why?
| | Health Education | 1 | 2015 | 179 | 0.110 |
Why?
| | Diagnostic Imaging | 2 | 2011 | 184 | 0.110 |
Why?
| | Oximetry | 1 | 2012 | 62 | 0.110 |
Why?
| | Tomography, X-Ray Computed | 1 | 2018 | 1213 | 0.110 |
Why?
| | Molecular Imaging | 1 | 2012 | 60 | 0.100 |
Why?
| | Kinetics | 1 | 2013 | 692 | 0.100 |
Why?
| | Sclera | 1 | 2011 | 6 | 0.100 |
Why?
| | Glycerol | 1 | 2011 | 22 | 0.100 |
Why?
| | Choroid | 1 | 2011 | 26 | 0.100 |
Why?
| | Computer Simulation | 2 | 2012 | 332 | 0.100 |
Why?
| | Skin Temperature | 1 | 2011 | 19 | 0.100 |
Why?
| | Body Temperature | 1 | 2011 | 83 | 0.100 |
Why?
| | Epithelium | 1 | 2010 | 68 | 0.100 |
Why?
| | Microvessels | 1 | 2010 | 34 | 0.090 |
Why?
| | Reactive Oxygen Species | 1 | 2013 | 491 | 0.090 |
Why?
| | Adenocarcinoma | 1 | 2014 | 428 | 0.090 |
Why?
| | Artifacts | 1 | 2011 | 61 | 0.090 |
Why?
| | Neoplasms | 1 | 2020 | 1316 | 0.090 |
Why?
| | Lung | 1 | 2013 | 507 | 0.090 |
Why?
| | Computer-Aided Design | 1 | 2010 | 21 | 0.090 |
Why?
| | Immunotherapy | 2 | 2022 | 263 | 0.090 |
Why?
| | Pilot Projects | 1 | 2010 | 808 | 0.080 |
Why?
| | Predictive Value of Tests | 1 | 2010 | 1048 | 0.080 |
Why?
| | Time Factors | 1 | 2013 | 3213 | 0.070 |
Why?
| | Brain | 1 | 2013 | 1387 | 0.060 |
Why?
| | Buthionine Sulfoximine | 1 | 2024 | 17 | 0.060 |
Why?
| | Carboplatin | 1 | 2024 | 62 | 0.060 |
Why?
| | Drug Resistance, Neoplasm | 1 | 2024 | 309 | 0.050 |
Why?
| | Light | 2 | 2012 | 82 | 0.050 |
Why?
| | Cisplatin | 1 | 2024 | 352 | 0.050 |
Why?
| | Mice, Inbred A | 1 | 2020 | 12 | 0.050 |
Why?
| | Mice, Obese | 1 | 2019 | 22 | 0.040 |
Why?
| | Precancerous Conditions | 1 | 2020 | 93 | 0.040 |
Why?
| | Phenotype | 1 | 2022 | 820 | 0.040 |
Why?
| | Macrophages | 1 | 2022 | 405 | 0.040 |
Why?
| | Mitochondrial Proteins | 1 | 2019 | 121 | 0.040 |
Why?
| | Down-Regulation | 1 | 2019 | 388 | 0.040 |
Why?
| | Gene Deletion | 1 | 2018 | 293 | 0.040 |
Why?
| | Tooth Apex | 1 | 2016 | 1 | 0.040 |
Why?
| | Optical Fibers | 1 | 2016 | 10 | 0.040 |
Why?
| | Shear Strength | 1 | 2016 | 11 | 0.040 |
Why?
| | Cell Size | 1 | 2016 | 45 | 0.040 |
Why?
| | Disease Progression | 1 | 2020 | 913 | 0.040 |
Why?
| | Body Weight | 1 | 2019 | 578 | 0.040 |
Why?
| | Stress, Mechanical | 1 | 2016 | 96 | 0.030 |
Why?
| | Keratinocytes | 1 | 2016 | 96 | 0.030 |
Why?
| | Neoplasm Transplantation | 1 | 2014 | 94 | 0.030 |
Why?
| | Halogenation | 1 | 2013 | 8 | 0.030 |
Why?
| | Transplantation, Heterologous | 1 | 2013 | 77 | 0.030 |
Why?
| | Iodine Radioisotopes | 1 | 2013 | 43 | 0.030 |
Why?
| | MCF-7 Cells | 1 | 2013 | 79 | 0.030 |
Why?
| | Blood Flow Velocity | 1 | 2013 | 114 | 0.030 |
Why?
| | Aerobiosis | 1 | 2013 | 16 | 0.030 |
Why?
| | Mice, Inbred C57BL | 1 | 2019 | 1999 | 0.030 |
Why?
| | Isotope Labeling | 1 | 2013 | 58 | 0.030 |
Why?
| | Signal Processing, Computer-Assisted | 1 | 2014 | 92 | 0.030 |
Why?
| | Mice, SCID | 1 | 2013 | 196 | 0.030 |
Why?
| | Rats, Nude | 1 | 2012 | 2 | 0.030 |
Why?
| | Aging | 1 | 2019 | 784 | 0.030 |
Why?
| | Superoxide Dismutase | 1 | 2013 | 125 | 0.030 |
Why?
| | Cell Hypoxia | 1 | 2012 | 87 | 0.030 |
Why?
| | Cells, Cultured | 1 | 2016 | 1737 | 0.030 |
Why?
| | Young Adult | 2 | 2014 | 4318 | 0.030 |
Why?
| | Diffusion | 1 | 2011 | 20 | 0.030 |
Why?
| | Monte Carlo Method | 1 | 2012 | 99 | 0.030 |
Why?
| | Optical Phenomena | 1 | 2011 | 11 | 0.030 |
Why?
| | Melanins | 1 | 2011 | 30 | 0.030 |
Why?
| | Diagnostic Techniques, Ophthalmological | 1 | 2011 | 22 | 0.030 |
Why?
| | Osmolar Concentration | 1 | 2011 | 83 | 0.030 |
Why?
| | Eye | 1 | 2011 | 36 | 0.020 |
Why?
| | Cricetinae | 1 | 2011 | 209 | 0.020 |
Why?
| | Pressure | 1 | 2011 | 120 | 0.020 |
Why?
| | Models, Animal | 1 | 2011 | 255 | 0.020 |
Why?
| | Rabbits | 1 | 2011 | 425 | 0.020 |
Why?
| | Male | 3 | 2019 | 27334 | 0.020 |
Why?
| | Regression Analysis | 1 | 2011 | 445 | 0.020 |
Why?
| | Obesity | 1 | 2019 | 1202 | 0.020 |
Why?
| | Swine | 1 | 2011 | 431 | 0.020 |
Why?
| | Treatment Outcome | 1 | 2018 | 5604 | 0.020 |
Why?
| | Adult | 2 | 2014 | 14207 | 0.020 |
Why?
| | Rats | 1 | 2012 | 3415 | 0.020 |
Why?
| | Aged, 80 and over | 1 | 2014 | 3431 | 0.020 |
Why?
| | Aged | 1 | 2014 | 10054 | 0.010 |
Why?
| | Adolescent | 1 | 2011 | 6897 | 0.010 |
Why?
| | Middle Aged | 1 | 2014 | 13088 | 0.010 |
Why?
|
|
Rajaram's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically based on a person's publications. Keywords from attributed publications are matched to keywords from the MeSH. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
|